Parexel Completes Separation of Parexel Informatics and Medical Imaging Business
January 11, 2021 06:00 ET
|
Parexel International LLC
Strategic move enhances value and growth for both companiesParexel Informatics to relaunch as Calyx BOSTON and DURHAM, N.C., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of...
Parexel Names Clare Grace to Newly-Created Role of Chief Patient Officer
January 04, 2021 10:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Joins Decentralized Trials & Research Alliance (DTRA) to Enhance Patient Access, Increase Diversity and Accelerate Trial Timelines
December 14, 2020 12:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Named Best Contract Research Organization by Scrip
December 03, 2020 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel und CTC North erhöhen gemeinsam Forschungskapazität für Durchführung früher klinischer Studien
November 23, 2020 15:03 ET
|
Parexel International LLC
BOSTON und DURHAM, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Parexel, ein führender Anbieter von Lösungen, die die Entwicklung und Bereitstellung innovativer Therapien – von der klinischen Phase bis...
Parexel Partners with CTC North to Increase Research Capacity for Delivery of Early Phase Clinical Trials
November 23, 2020 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 02, 2020 09:30 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Biotech Collaborates with Synairgen on Pivotal Phase III Trial for Study of Inhaled COVID-19 Treatment
October 20, 2020 07:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic
September 24, 2020 09:00 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C. and ESCHBORN, Germany , Sept. 24, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to...
Parexel Completes Purchase of Roam Analytics’ Natural Language Processing Capability
September 22, 2020 11:35 ET
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...